Skip to results
1-4 of 4
Authors: Ian A Strohbehn
Sort by
Journal Article
EDITOR'S CHOICE
The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score–Matched Study Open Access
Ian A Strohbehn and others
Open Forum Infectious Diseases, Volume 12, Issue 1, January 2025, ofae756, https://doi.org/10.1093/ofid/ofae756
Published: 31 December 2024
Journal Article
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study Open Access
Bruce C Tiu and others
The Oncologist, Volume 28, Issue 6, June 2023, Pages e379–e390, https://doi.org/10.1093/oncolo/oyad001
Published: 23 February 2023
Journal Article
Immune checkpoint inhibitor–induced thyroiditis is a risk factor for acute and chronic kidney dysfunction Free
Ian A Strohbehn and others
Nephrology Dialysis Transplantation, Volume 37, Issue 1, January 2022, Pages 187–189, https://doi.org/10.1093/ndt/gfab240
Published: 12 August 2021
Journal Article
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib Free
Harish Seethapathy and others
Nephrology Dialysis Transplantation, Volume 37, Issue 3, March 2022, Pages 507–514, https://doi.org/10.1093/ndt/gfaa372
Published: 23 December 2020